Kashiwa, Japan

Ryuta Sato

This inventor holds 1 USPTO granted patent. Top assignees: Nanocarrier Co., Ltd., National Cancer Center, Riken Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuta Sato. Retrieved from https://idiyas.com/inventor/ryuta-sato-tcdhi10x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ryuta Sato

Introduction

Ryuta Sato is a notable inventor from Kashiwa, Japan, known for his contributions to the field of biomedicine, particularly through his work on monoclonal antibodies. With a focus on therapeutic methods and drug delivery systems, he has made significant strides in addressing health challenges related to tissue factors.

Latest Patents

Ryuta Sato holds a patent for an "Anti-tissue factor monoclonal antibody." This patent includes details on monoclonal antibodies that target human and mouse tissue factors, along with their fragments. It also encompasses various pharmaceutical compositions and drug delivery systems utilizing these antibodies. The therapeutic methods outlined in this patent provide potential advancements in medical treatments.

Career Highlights

Throughout his career, Ryuta Sato has collaborated with prominent institutions, working with the National Cancer Center and The University of Tokyo. His research has significantly contributed to the understanding and development of innovative solutions in cancer therapies and other related fields.

Collaborations

In his professional journey, Sato has partnered with other esteemed researchers, including Yasuhiro Matsumura and Masahiro Yasunaga. These collaborations have further enhanced the development of his inventions and the impact of his work in the scientific community.

Conclusion

Ryuta Sato exemplifies the spirit of innovation in biomedical research. His patented work on monoclonal antibodies represents a crucial advancement that could lead to improved therapeutic options for patients. As an inventor, his contributions continue to inspire future research and development in health sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…